Neoplasms, Second PrimaryLymphomaLymphoma, Non-HodgkinWorld Health OrganizationLeukemia, B-CellSOXC Transcription FactorsHodgkin DiseaseLeukemiaLymphoma, T-CellLymphoma, B-CellNeoplasms, Multiple PrimaryLeukemia, LymphoidLymphoma, Mantle-CellHematologic NeoplasmsLymphoproliferative DisordersLymphoma, Large B-Cell, DiffuseHead and Neck NeoplasmsImmunophenotypingNeoplasms, Radiation-InducedImmunohistochemistryCarcinoma, Squamous CellIsotretinoinNeoplasm Recurrence, LocalLung NeoplasmsSkin NeoplasmsIncidenceNeoplasmsOtorhinolaryngologic NeoplasmsPancreatic NeoplasmsImmunoproliferative DisordersNeoplasm StagingRadiotherapyRisk FactorsFollow-Up StudiesBreast NeoplasmsNervous System NeoplasmsTooth ExfoliationLaryngeal NeoplasmsEye NeoplasmsOropharyngeal NeoplasmsMouth NeoplasmsSurvivorsRiskRetrospective StudiesThyroid NeoplasmsRegistriesNeoplasms, Cystic, Mucinous, and SerousSEER ProgramRetinoblastomaChromium CompoundsKidney NeoplasmsSurvival RatePharyngeal NeoplasmsHypopharyngeal NeoplasmsTime FactorsNeoplasm MetastasisProportional Hazards ModelsOvarian NeoplasmsPrognosisSurvival AnalysisAge FactorsSmokingTooth, DeciduousAnticarcinogenic AgentsCombined Modality TherapyCohort StudiesMelanomaGenes, p53CarcinomaQueenslandDisease-Free SurvivalMaintenance ChemotherapyAdenocarcinomaStomach NeoplasmsCarcinoma, Basal CellCase-Control StudiesColonic NeoplasmsPneumonectomyLoss of HeterozygosityRisk AssessmentTreatment OutcomeNeoplasms, Squamous CellColorectal NeoplasmsAdenocarcinoma, MucinousEsophageal NeoplasmsCarcinoma, Small CellMyeloproliferative DisordersTomography, X-Ray ComputedNuclear WarfareActuarial AnalysisTumor Markers, BiologicalMolarDNA, NeoplasmParotid NeoplasmsGenetic Predisposition to DiseasePoisson DistributionCystadenomaDose FractionationNeoplasms, Connective and Soft TissuePrecancerous Conditions